The safety of intravenous iron sucrose use in the elderly patient

Consultant Pharmacist

Volumn 22, Issue 3, 2007, Pages 230-238

  Reed, John ^a   Charytan, Chaim ^b,c   Yee, Jerry ^d,e  

^a FMC NA Clinics of Southeast   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e Greenfield Health Systems   (United States)

Author keywords

Anemia; Chronic kidney disease; Clinical practice guidelines; Erythropoietin; Ferritin; Hemodialysis dependent; Iron sucrose; Iron therapy; National kidney foundation dialysis outcomes quality initiative; Transferrin saturation

Indexed keywords

FERRIC HYDROXIDE SUCROSE; FERRITIN; HEMOGLOBIN; TRANSFERRIN; ANTIANEMIC AGENT; ERYTHROPOIETIN; FERRIC ION; FERRIC OXIDE, SACCHARATED; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FERRITIN BLOOD LEVEL; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OPEN STUDY; PATIENT COMPLIANCE; PNEUMONIA; PRURITUS; SEPSIS; TASTE DISORDER; THORAX PAIN; TRANSFERRIN BLOOD LEVEL; AGE; CHRONIC KIDNEY FAILURE; GERIATRICS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; ERYTHROPOIETIN; FEMALE; FERRIC COMPOUNDS; GERIATRICS; HEMATINICS; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 34548422821     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2007.230     Document Type: Article

References (24)